4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001359820-08-000003
Interim CEO bought 17,200 shares at an average $0.22 ($3,863)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Babcock Dwight William Interim CEO | 2008-12-10 | Purchase | +200 | $0.21 | $42 | 63,507 | D: show line 1 in the form |
| Babcock Dwight William Interim CEO | 2008-12-11 | Purchase | +800 | $0.21 | $168 | 64,307 | D: show line 2 in the form |
| Babcock Dwight William Interim CEO | 2008-12-12 | Purchase | +7,300 | $0.22 | $1,606 | 71,607 | D: show line 3 in the form |
| Babcock Dwight William Interim CEO | 2008-12-18 | Purchase | +8,900 | $0.23 | $2,047 | 80,507 | D: show line 4 in the form |
| Open-market purchases · 17,200 sh · avg $0.22 · $3,863 | |||||||
Loading xslF345X03/primary_doc.xml…